NCT00367458View on ClinicalTrials.gov

Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 18, 2006

Primary Completion Date

June 19, 2008

Study Completion Date

June 19, 2008

Conditions

HIV

Interventions

DRUG

Atorvastatin

80 mg atorvastatin oral daily

DRUG

Placebo

patients will be administered placebo

Trial Locations (3)

20889

National Naval Medical Center, Bethesda

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

92134-5000

Naval Medical Center, San Diego, San Diego

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00367458 - Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy | Biotech Hunter | Biotech Hunter